journal article·2026-06-16Open access

Machine Learning-Based Severity Classification in Decompensated Liver Cirrhosis: Incremental Value of Oxidative Stress Biomarkers for Predicting Ascites and Hepatic Encephalopathy

Vlad Pădureanu, Florentina Dumitrescu, Rodica Pădureanu, Dragoș Forțofoiu, Dalia Dop, Vlad Dumitru Baleanu, Roni Octavian Damian, Răzvan Radu Mititelu, Lidia Boldeanu, Virginia Maria Rădulescu

Applied Sciences· Volume 16· Issue 12

Abstract

Oxidative stress biomarkers are elevated in liver cirrhosis, but their clinical utility for severity staging and complication prediction remains uncertain. This retrospective single-centre study enrolled 90 patients with decompensated cirrhosis (Child–Pugh classes B and C) to evaluate serum malondialdehyde (MDA) and 8-isoprostane (8-isoPGF2α) as predictors of Child–Pugh severity, severe ascites, and severe hepatic encephalopathy, and to quantify their incremental value within supervised machine learning models. Four algorithms—logistic regression, Random Forest, Gradient Boosting, and Support Vector Machine—were evaluated using stratified 10-fold cross-validation; logistic regression models with and without oxidative stress biomarkers were compared for the prediction of ascites and encephalopathy. Routine biochemical parameters effectively discriminated Child–Pugh class B from C, with machine learning models achieving AUC-ROC values of 0.921–0.972. Neither MDA nor 8-isoPGF2α differed between Child–Pugh classes or across ascites categories, and both failed to improve ascites prediction (ΔAUC = −0.015). For severe hepatic encephalopathy, the extended model showed modest but consistent improvements in accuracy (+3.4 percentage points), sensitivity (+6.4%), and model fit, suggesting an outcome-specific complementary role consistent with the established involvement of lipid peroxidation in ammonia neurotoxicity. These findings support the use of machine learning for automated cirrhosis severity classification and indicate that oxidative stress biomarkers hold selective relevance for hepatic encephalopathy rather than global disease staging.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Liver Disease and Transplantation · Liver Disease Diagnosis and Treatment · Hepatocellular Carcinoma Treatment and Prognosis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

Department of Infectious Disease, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

Department of Pediatrics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

Department of Surgery, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania

Emergency Medicine and First Aid Department, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

Department of Microbiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

Department of Medical Informatics and Biostatistics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

Funding

University of Medicine and Pharmacy of Craiova

References (31)

Show source-provided references
2. Burden of liver diseases in the world10.1016/j.jhep.2018.09.014 ↗
3. Global epidemiology of cirrhosis—Aetiology, trends and predictions10.1038/s41575-023-00759-2 ↗
4. Global burden of liver disease: 2023 update10.1016/j.jhep.2023.03.017 ↗
5. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis10.1016/j.jhep.2018.03.024 ↗
6. Transection of the oesophagus for bleeding oesophageal varices10.1002/bjs.1800600817 ↗
7. Artificial intelligence-based evaluation of prognosis in cirrhosis10.1186/s12967-024-05726-2 ↗
8. A model to predict survival in patients with end-stage liver disease10.1053/jhep.2001.22172 ↗
9. MELD 3.0: The model for end-stage liver disease updated for the 21st century
10. Machine learning-based system for prediction of ascites grades in patients with liver cirrhosis using laboratory and clinical data10.1515/cclm-2022-0454 ↗
11. Lin, Y.J., Chen, R.J., Tang, J.H., Yu, C.S., Wu, J.L., Chen, L.C., and Chang, S.S. (2025). Machine learning-based prediction of decompensation in hepatitis B virus-related cirrhosis. Diagnostics, 15.10.3390/diagnostics15212790 ↗
12. Oxidative stress as a crucial factor in liver diseases10.3748/wjg.v20.i25.8082 ↗
13. Teschke, R., and Danan, G. (2023). Oxidative stress in liver pathophysiology and disease. Antioxidants, 12.10.3390/antiox12091653 ↗
14. Oxidative stress, isoprostanes and hepatic fibrosis
15. Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure10.1007/s10620-009-0990-2 ↗
16. Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective10.1016/j.ajg.2018.03.002 ↗
17. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver10.1002/hep.27210 ↗
18. Guidelines on the management of ascites in cirrhosis10.1136/gut.2006.099580 ↗
19. European Association for the Study of the Liver (2022). EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. J. Hepatol., 77, 807–855.
20. Multiphase CT-based prediction of Child-Pugh classification: A machine learning approach10.1186/s41747-020-00148-3 ↗
21. Machine learning-powered 28-day mortality prediction in decompensated liver cirrhosis10.5001/omj.2024.79 ↗
22. Chen, X., Wang, Y., Xu, L., Zhang, Y., Lin, X., and Qian, J. (2025). Ascites complications risk factors of decompensated cirrhosis patients: Logistic regression and prediction model. BMC Gastroenterol., 25.10.1186/s12876-025-04002-x ↗
23. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis and spontaneous bacterial peritonitis?
24. Oxidative stress markers in patients with liver cirrhosis: Lack of association with Child–Pugh score and ascites severity
25. Using machine learning methods to predict hepatic encephalopathy in cirrhotic patients with unbalanced data
26. Shi, M., Chen, F., Hong, Z., Yao, A., Liu, Y., Chen, H., and Chen, H. (2023). Cellular pathogenesis of hepatic encephalopathy: An update. Biomolecules, 13.10.3390/biom13020396 ↗
27. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy10.1016/j.jhep.2020.07.013 ↗
28. Sfarti, C., Ciobica, A., Balmus, I.M., Ilie, O.D., Trifan, A., Petrea, O., Cojocariu, C., Gîrleanu, I., Sîngeap, A.M., and Stanciu, C. (2020). Systemic oxidative stress markers in cirrhotic patients with hepatic encephalopathy: Possible connections with systemic ammoniemia. Medicina, 56.10.3390/medicina56040196 ↗
29. GC–MS and GC–MS/MS measurement of malondialdehyde (MDA) in clinical studies: Pre-analytical and clinical considerations
30. Development and validation of a machine learning-based model to predict survival in patients with cirrhosis after transjugular intrahepatic portosystemic shunt10.1016/j.eclinm.2024.103001 ↗
31. Liu, Y., Ding, K., Qiu, Y., Wang, P., Wang, R., Zeng, X., and Yin, C. (2025). Interpretable machine learning model for predicting covert hepatic encephalopathy in patients with cirrhosis: A multicenter study. Front. Med., 12.10.3389/fmed.2025.1686005 ↗